Thermo Fisher Scientific Inc. (TMO)
Automate Your Wheel Strategy on TMO
With Tiblio's Option Bot, you can configure your own wheel strategy including TMO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowNews
Is This the Right Time to Hold Thermo Fisher Stock in Your Portfolio?
Published: March 06, 2026 by: Zacks Investment Research
Sentiment: Neutral
TMO's acquisitions and resilient pharma, biotech and diagnostics demand support growth, but currency swings and fierce competition remain risks.
Read More
Thermo Fisher Scientific Inc. (TMO) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
Published: March 03, 2026 by: Seeking Alpha
Sentiment: Neutral
Thermo Fisher Scientific Inc. (TMO) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
Read More
Thermo Fisher Scientific: Recovery In Life Sciences Solutions
Published: March 02, 2026 by: Seeking Alpha
Sentiment: Positive
Thermo Fisher Scientific is reiterated as a 'buy' with a fair value estimate of $619 per share, reflecting confidence in its recovery and strategic positioning. TMO's acquisition of Clario Holdings for $8.875 billion is expected to enhance recurring revenue, accelerate organic growth, and support future AI-driven clinical trial solutions. Management guides for 3%-4% organic revenue growth and 6%-8% adjusted EPS growth in FY26, underpinned by improving biotech funding and market sentiment.
Read More
Thermo Fisher Scientific Inc. (TMO) Q4 2025 Earnings Call Transcript
Published: January 29, 2026 by: Seeking Alpha
Sentiment: Neutral
Thermo Fisher Scientific Inc. (TMO) Q4 2025 Earnings Call Transcript
Read More
Thermo Fisher Scientific Discloses How Much Clario Deal Could Add To Its EPS
Published: January 29, 2026 by: Benzinga
Sentiment: Positive
Thermo Fisher Scientific Inc. (NYSE: TMO) on Thursday reported fourth-quarter 2025 adjusted earnings of $6.57 per share, beating the street view of $6.45.
Read More
Thermo Fisher stock slides on cautious profit guidance
Published: January 29, 2026 by: Proactive Investors
Sentiment: Negative
Thermo Fisher Scientific Inc (NYSE:TMO, XETRA:TN8) delivered a fourth quarter earnings beat, but its shares moved lower as investors focused on margin pressures and cautious earnings guidance for 2026. The life sciences tools and diagnostics company guided 2026 revenue to a range of $46.3 billion to $47.2 billion, implying 4% to 6% growth and organic growth of 3% to 4%, broadly in line with consensus expectations and indicating continued modest demand across biopharma and life sciences end markets.
Read More
Thermo Fisher (TMO) Reports Q4 Earnings: What Key Metrics Have to Say
Published: January 29, 2026 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Thermo Fisher (TMO) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Thermo Fisher's Q4 Earnings & Revenues Top Estimates, Stock Climbs
Published: January 29, 2026 by: Zacks Investment Research
Sentiment: Positive
TMO beats Q4 EPS and revenue estimates, posts 7.1% sales growth, and sees shares rise after results despite margin pressure.
Read More
Countdown to Thermo Fisher (TMO) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Published: January 26, 2026 by: Zacks Investment Research
Sentiment: Positive
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Thermo Fisher (TMO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.
Read More
Thermo Fisher Scientific (TMO) Reports Next Week: Wall Street Expects Earnings Growth
Published: January 22, 2026 by: Zacks Investment Research
Sentiment: Positive
Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Thermo Fisher Scientific Inc. (TMO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Published: January 13, 2026 by: Seeking Alpha
Sentiment: Neutral
Thermo Fisher Scientific Inc. (TMO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Read More
Thermo Fisher wins contracts as pharma shifts production to US, CEO says
Published: January 13, 2026 by: Reuters
Sentiment: Positive
Thermo Fisher Scientific's pharmaceutical services business has won a number of contracts to help its customers move production from Europe or Asia to the U.S., the medical equipment maker's CEO, Marc Casper, said on Tuesday.
Read More
There Is a Quiet But Massive Migration Away From Tech Stocks in 2026
Published: January 09, 2026 by: 24/7 Wall Street
Sentiment: Negative
In the last three months of 2025, the tech sector experienced what some called a “correction”.
Read More
Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report?
Published: January 06, 2026 by: Zacks Investment Research
Sentiment: Positive
Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Published: December 30, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Read More
TMO Stock May Benefit From PPD CorEvitas Alzheimer's Registry Launch
Published: December 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Thermo Fisher launches a global PPD CorEvitas Alzheimer's registry, enrolling its first patient to generate real-world safety and effectiveness data.
Read More
Calls of the Day: Netflix, Thermo Fisher, Incyte and Shake Shack
Published: December 09, 2025 by: CNBC Television
Sentiment: Neutral
The Investment Committee debate the latest Calls of the Day.
Read More
TMO Stock Benefits From New Bioprocess Design Center in Asia
Published: December 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Thermo Fisher expands its Bioprocess Design Centers across Asia, boosting biomanufacturing speed, efficiency and regional innovation.
Read More
Why Is Thermo Fisher (TMO) Up 0.2% Since Last Earnings Report?
Published: November 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock?
Read More
Institutions Love These 3 Companies, Should You As Well?
Published: November 19, 2025 by: MarketBeat
Sentiment: Positive
A common strategy among retail investors is to mirror the investment moves of successful firms and market leaders. Poring over the Form 13-F results of gurus like Warren Buffett can reveal valuable insights, albeit on a delayed schedule.
Read More
These 3 Stocks Are Using Buybacks to Signal Market Confidence
Published: November 18, 2025 by: MarketBeat
Sentiment: Positive
Several key stocks are making notable buyback announcements. Below, we examine the latest moves by Trade Desk, Thermo Fisher, and Tapestry—and what they reveal about each company's capital return strategy.
Read More
Thermo Fisher Scientific Opens East Coast Collaboration Center at BioLabs for Advanced Therapeutics to Help Accelerate Cell and Gene Therapy Development
Published: November 18, 2025 by: Business Wire
Sentiment: Neutral
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the grand opening of its East Coast flagship Advanced Therapies Collaboration Center (ATxCC) in Philadelphia, marking the company's second ATxCC in the United States following the opening of its Carlsbad, California, site. Together, these centers expand the company's nationwide network supporting cell and gene therapy (CGT) innovation, providing critical resources to biotech, bio.
Read More
Artisan Value Fund Q3 2025 Top Contributors And Detractors
Published: November 14, 2025 by: Seeking Alpha
Sentiment: Neutral
Our biggest source of underperformance was the consumer staples sector as we had a number of laggards, including Kerry Group, Philip Morris and Diageo. On the positive side, the three new purchases we made in Q2 during the post-Liberation Day market meltdown—Lam Research, ASML and Thermo Fisher Scientific—were each among our top contributors to returns in Q3. Our top contributor in Q3 was Alphabet, a long-time holding.
Read More
Sethi: Thermo Fisher is a world-class compounder you want in your portfolio
Published: October 29, 2025 by: CNBC Television
Sentiment: Positive
Sarat Sethi, Managing Partner at DCLA, highlights opportunities in undervalued sectors like healthcare and diagnostics, says trade clarity could boost growth, and calls Thermo Fisher a standout pick.
Read More
Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 Billion
Published: October 29, 2025 by: WSJ
Sentiment: Positive
Thermo Fisher Scientific agreed to acquire endpoint data solutions provider Clario Holdings from a shareholder group for $8.88 billion in cash.
Read More
Thermo Fisher to buy clinical services provider Clario
Published: October 29, 2025 by: Reuters
Sentiment: Positive
Thermo Fisher said on Wednesday it would buy privately held data management company Clario for about $8.9 billion in cash and future payments, strengthening the life science firm's presence in digital health and clinical trial research.
Read More
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights
Published: October 29, 2025 by: Business Wire
Sentiment: Neutral
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a definitive agreement to acquire Clario Holdings, Inc., a leading provider of endpoint data solutions for clinical trials, from a shareholder group led by Astorg and Nordic Capital, Novo Holding and Cinven, for $8.875 billion in cash at close plus potential additional earnout and other payments in the future, largely dependent on performance. Clario integrates clinic.
Read More
14-year-old Combines Origami and Physics to Engineer Foldable Structures for Disaster Relief Shelters; Wins $25,000 Top Award at Thermo Fisher Scientific Junior Innovators Challenge
Published: October 28, 2025 by: GlobeNewsWire
Sentiment: Neutral
Miles Wu, 14, from New York City, won the $25,000 Thermo Fisher Scientific ASCEND Award, the top award in the Thermo Fisher Junior Innovators Challenge.
Read More
Pre-Market Futures Flat at This Hour
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Neutral
Pre-Market Futures Flat at This Hour.
Read More
Q3 Earnings Bonanza Pulls a Flat Pre-Market: T, TMO, TSLA, etc.
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Q3 earnings reports released yesterday afternoon did not quite have the positive sheen we've seen elsewhere this far into earnings season.
Read More
About Thermo Fisher Scientific Inc. (TMO)
- IPO Date 1980-03-17
- Website https://www.thermofisher.com
- Industry Medical - Diagnostics & Research
- CEO Marc N. Casper
- Employees 125000